Rapid, stable, chemoselective labeling of thiols with Julia-Kocieński-like reagents: a serum-stable alternative to maleimide-based protein conjugation.
暂无分享,去创建一个
[1] C. Stedman,et al. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors , 2000, Alimentary pharmacology & therapeutics.
[2] Christian P. R. Hackenberger,et al. Chemoselektive Ligations‐ und Modifikationsstrategien für Peptide und Proteine , 2008 .
[3] W. J. Cole,et al. A Stereoselective Synthesis of trans-1,2-Disubstituted Alkenes Based on the Condensation of Aldehydes with Metallated 1-Phenyl-1H-tetrazol-5-yl Sulfones , 1998 .
[4] D. Schwarzer,et al. Chemoselective ligation and modification strategies for peptides and proteins. , 2008, Angewandte Chemie.
[5] Anna M Wu,et al. Arming antibodies: prospects and challenges for immunoconjugates , 2005, Nature Biotechnology.
[6] C. Barbas,et al. Tyrosine bioconjugation through aqueous ene-type reactions: a click-like reaction for tyrosine. , 2010, Journal of the American Chemical Society.
[7] C. Barbas,et al. Facile and stabile linkages through tyrosine: bioconjugation strategies with the tyrosine-click reaction. , 2013, Bioconjugate chemistry.
[8] J. Baudin,et al. A direct synthesis of olefins by reaction of carbonyl compounds with lithio derivatives of 2-[alkyl- or (2'-alkenyl)- or benzyl-sulfonyl]-benzothiazoles , 1991 .
[9] I. Carrico. Chemoselective modification of proteins: hitting the target. , 2008, Chemical Society reviews.
[10] Carolyn R Bertozzi,et al. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. , 2009, Angewandte Chemie.
[11] C. Won,et al. PEG-modified biopharmaceuticals , 2009 .
[12] D. Rognan,et al. Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. , 2002, Journal of medicinal chemistry.
[13] P Argos,et al. Oligopeptide biases in protein sequences and their use in predicting protein coding regions in nucleotide sequences , 1988, Proteins.
[14] F. Veronese,et al. The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.
[15] Stephen C Alley,et al. Antibody-drug conjugates: targeted drug delivery for cancer. , 2010, Current opinion in chemical biology.
[16] Yousuke Takaoka,et al. Organische Proteinchemie und ihre Anwendung für Markierungen und Engineering in Lebendzellsystemen , 2013 .
[17] D. Liebler,et al. Reversibility of covalent electrophile-protein adducts and chemical toxicity. , 2008, Chemical research in toxicology.
[18] B. G. Davis,et al. Chemical modification of proteins at cysteine: opportunities in chemistry and biology. , 2009, Chemistry, an Asian journal.
[19] C. Barbas,et al. Antibody Conjugation Approach Enhances Breadth and Potency of Neutralization of Anti-HIV-1 Antibodies and CD4-IgG , 2013, Journal of Virology.
[20] E. Sletten,et al. Bioorthogonale Chemie – oder: in einem Meer aus Funktionalität nach Selektivität fischen , 2009 .
[21] Itaru Hamachi,et al. Protein organic chemistry and applications for labeling and engineering in live-cell systems. , 2013, Angewandte Chemie.
[22] M. Xian,et al. Methylsulfonyl benzothiazole (MSBT): a selective protein thiol blocking reagent. , 2012, Organic letters.
[23] H. Satoh,et al. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. , 1989, The Journal of pharmacology and experimental therapeutics.
[24] M. Sliwkowski,et al. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates , 2012, Nature Biotechnology.
[25] Damon L. Meyer,et al. Contribution of linker stability to the activities of anticancer immunoconjugates. , 2008, Bioconjugate chemistry.
[26] K. Kiick,et al. Tunable degradation of maleimide-thiol adducts in reducing environments. , 2011, Bioconjugate chemistry.
[27] Felix Kratz,et al. Synthesis, Cleavage Profile, and Antitumor Efficacy of an Albumin‐Binding Prodrug of Methotrexate that is Cleaved by Plasmin and Cathepsin B , 2007, Archiv der Pharmazie.